BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25299431)

  • 1. Highly sensitive and selective anticancer effect by conjugated HA-cisplatin in non-small cell lung cancer overexpressed with CD44.
    Quan YH; Kim B; Park JH; Choi Y; Choi YH; Kim HK
    Exp Lung Res; 2014 Dec; 40(10):475-84. PubMed ID: 25299431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases.
    Ma L; Wang R; Nan Y; Li W; Wang Q; Jin F
    Int J Oncol; 2016 Feb; 48(2):843-53. PubMed ID: 26692364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
    Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of an enhanced aggressive phenotype in human lung cancer cells selected by suboptimal doses of cisplatin following cell deattachment and reattachment.
    Hsieh JL; Lu CS; Huang CL; Shieh GS; Su BH; Su YC; Lee CH; Chang MY; Wu CL; Shiau AL
    Cancer Lett; 2012 Aug; 321(1):36-44. PubMed ID: 22450752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishable Targeting of Non-Small Cell Lung Cancer Using Hyaluronan Functionalized Platinum Nanoclusters and Their Inhibition Behaviors of Proliferation, Invasion, Migration.
    Liu T; Huang X; Zhao L; Xiao Z; Li Z; Xin Y; Yang S; Guo D; Zhao W; Mi Y; Li H
    ChemistryOpen; 2021 Sep; 10(9):882-888. PubMed ID: 34363352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of bFGF following apoptosis and necrosis in NSCLC cells: effects on chemosensitivity to cisplatin.
    Kuhn H; Weser L; Gessner C; Hammerschmidt S; Wirtz H
    Oncol Rep; 2005 Sep; 14(3):759-62. PubMed ID: 16077988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance.
    Coleman KL; Chiaramonti M; Haddad B; Ranzenberger R; Henning H; Al Khashali H; Ray R; Darweesh B; Guthrie J; Heyl D; Evans HG
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
    Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
    Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
    Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell.
    Ohashi R; Takahashi F; Cui R; Yoshioka M; Gu T; Sasaki S; Tominaga S; Nishio K; Tanabe KK; Takahashi K
    Cancer Lett; 2007 Jul; 252(2):225-34. PubMed ID: 17276588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
    Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
    Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
    Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
    Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines.
    Teder P; Bergh J; Heldin P
    Cancer Res; 1995 Sep; 55(17):3908-14. PubMed ID: 7543820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
    Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
    Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells.
    Yin J; Zhang H; Wu X; Zhang Y; Li J; Shen J; Zhao Y; Xiao Z; Lu L; Huang C; Zhang Z; Du F; Wu Y; Kaboli PJ; Cho CH; Yuan D; Li M
    Int J Mol Med; 2020 Jun; 45(6):1783-1792. PubMed ID: 32236608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of ADAM8 against cisplatin-mediated apoptosis in non-small-cell lung cancer.
    Zhang W; Wan M; Ma L; Liu X; He J
    Cell Biol Int; 2013 Jan; 37(1):47-53. PubMed ID: 23319321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer Effects of Sinulariolide-Conjugated Hyaluronan Nanoparticles on Lung Adenocarcinoma Cells.
    Hsiao KY; Wu YJ; Liu ZN; Chuang CW; Huang HH; Kuo SM
    Molecules; 2016 Mar; 21(3):297. PubMed ID: 26950100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells.
    Weng SH; Tseng SC; Huang YC; Chen HJ; Lin YW
    Biochem Pharmacol; 2012 Jul; 84(1):126-36. PubMed ID: 22480737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.